1. Home
  2. CTNM vs TRAK Comparison

CTNM vs TRAK Comparison

Compare CTNM & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTNM
  • TRAK
  • Stock Information
  • Founded
  • CTNM 2009
  • TRAK 1990
  • Country
  • CTNM United States
  • TRAK United States
  • Employees
  • CTNM N/A
  • TRAK N/A
  • Industry
  • CTNM
  • TRAK EDP Services
  • Sector
  • CTNM
  • TRAK Technology
  • Exchange
  • CTNM Nasdaq
  • TRAK Nasdaq
  • Market Cap
  • CTNM 328.1M
  • TRAK 275.7M
  • IPO Year
  • CTNM 2024
  • TRAK 1998
  • Fundamental
  • Price
  • CTNM $11.01
  • TRAK $15.01
  • Analyst Decision
  • CTNM Strong Buy
  • TRAK
  • Analyst Count
  • CTNM 5
  • TRAK 0
  • Target Price
  • CTNM $22.20
  • TRAK N/A
  • AVG Volume (30 Days)
  • CTNM 92.7K
  • TRAK 62.7K
  • Earning Date
  • CTNM 10-30-2025
  • TRAK 11-13-2025
  • Dividend Yield
  • CTNM N/A
  • TRAK 0.53%
  • EPS Growth
  • CTNM N/A
  • TRAK 20.69
  • EPS
  • CTNM N/A
  • TRAK 0.35
  • Revenue
  • CTNM N/A
  • TRAK $22,606,066.00
  • Revenue This Year
  • CTNM N/A
  • TRAK $12.20
  • Revenue Next Year
  • CTNM N/A
  • TRAK $20.00
  • P/E Ratio
  • CTNM N/A
  • TRAK $42.89
  • Revenue Growth
  • CTNM N/A
  • TRAK 10.53
  • 52 Week Low
  • CTNM $3.35
  • TRAK $13.87
  • 52 Week High
  • CTNM $20.24
  • TRAK $25.01
  • Technical
  • Relative Strength Index (RSI)
  • CTNM 48.88
  • TRAK 45.41
  • Support Level
  • CTNM $10.77
  • TRAK $14.35
  • Resistance Level
  • CTNM $11.34
  • TRAK $15.80
  • Average True Range (ATR)
  • CTNM 0.68
  • TRAK 0.50
  • MACD
  • CTNM -0.15
  • TRAK 0.09
  • Stochastic Oscillator
  • CTNM 31.37
  • TRAK 54.07

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

Share on Social Networks: